Tamispras Duo

Tamispras Duo combines tamsulosin hydrochloride and solifenacin succinate for managing symptoms of an enlarged prostate. This oral medication helps relieve urinary urgency and difficulty. It is prescribed to improve bladder control and reduce discomfort in men with benign prostatic hyperplasia. Suitable for adults as directed by a healthcare provider.

Tamispras Duo is used to treat symptoms associated with an enlarged prostate, such as frequent urination, urgency, and difficulty emptying the bladder. It combines two active ingredients to address both urinary flow issues and bladder overactivity. This medication is typically prescribed when symptoms are moderate to severe and impact daily life. It is not intended for use in women or children.

Users of Tamispras Duo may experience improved urinary flow and reduced urgency shortly after starting treatment. Some individuals notice a decrease in nighttime bathroom visits, leading to better sleep quality. Common effects include mild dizziness or dry mouth, which are usually temporary. These effects vary by individual and may lessen over time.

Tamispras Duo should be taken exactly as prescribed to minimize risks of side effects. It may cause dizziness, especially when standing up quickly, so caution is advised when driving or operating machinery. Avoid alcohol as it can worsen dizziness. Stay hydrated and report persistent side effects to a healthcare provider. Do not crush or chew the capsules.

Tamispras Duo may interact with other medications, including strong CYP3A4 inhibitors like ketoconazole or ritonavir, which can increase side effects. Blood pressure medications and diuretics may enhance dizziness. Grapefruit juice can also affect how the medication works. Always inform your healthcare provider about all medications and supplements you are taking.